Discover Important Digital Transformation Pillars in Pharmaceutical Formulations

Author: Reena Chaudhary, Global Brand & Digital Manager

The pharmaceutical industry is undergoing a significant shift towards digitalization, revolutionizing the way drugs are developed. Digital health tools are at the forefront of this transformation, enabling more efficient, data-driven solutions that enhance every stage of drug development. From early-stage discovery to clinical trials and beyond, digital technologies are reshaping the landscape, making processes faster, more accurate, and more collaborative. ^1,2

At IFF Pharma Solutions, we are embracing this digital revolution by leveraging advanced tools to improve access to data and insights and enhance excipient selection and formulation processes. Here are three innovative pillars we are focusing on to lead this change:

1. Making Product Information Readily Available with AnswerCenter

Our commitment to advancing pharmaceutical formulation processes is exemplified with AnswerCenter. Designed for formulators, researchers, and industry professionals, AnswerCenter provides quick access to critical information, streamlining the formulation process. Users can instantly access up-to-date safety data sheets (SDS) and technical data sheets (TDS), explore tools and resources for optimal excipient choices, and stay informed with regularly updated articles and expert insights. Additionally, sample ordering is made easy, allowing formulators to evaluate excipients firsthand.

By providing comprehensive and easily accessible information on excipients, AnswerCenter empowers formulators to make informed decisions, ultimately enhancing the efficiency and effectiveness of drug development.

2. Partnering and Collaborating to Leverage Industry Tools like ZoomLab^®

Our collaboration with BASF Pharma Solutions on the Virtual Pharma Assistant Platform, ZoomLab®, exemplifies the power of industry partnerships in driving innovation. ZoomLab® is a science-based digital tool that accurately predicts the best excipients needed for new pharmaceutical formulations, overcoming formulation challenges. Powered by BASF’s proprietary algorithm, ZoomLab® enables customers to predict advanced formulations based on active ingredient properties and target dosage profiles. In the first phase of our collaboration, IFF’s leading binder technology, Avicel® microcrystalline cellulose (MCC), and super disintegrant Ac-Di-Sol® croscarmellose sodium are available to users in ZoomLab®’s excipient database and throughout the various ZoomLab^® modules. These renowned excipients enhance the platform's offerings, providing robust solutions for formulation needs. Formulators can customize their choices from a range of high-quality ingredients, saving valuable time and resources while minimizing waste.³

ZoomLab^® offers several key features:

• Predictive Formulations: Enables customers to predict advanced formulations based on active ingredient properties and target dosage profiles.
• Customization: Allows formulators to choose from a range of high-quality excipients including IFF’s renowned products.
• Time and Cost Savings: Provides data-driven guidance to choose optimal formulations within minutes, reducing development time and costs.

3. Building Knowledge Platforms to Share Deep Insights

At IFF Pharma Solutions, we are dedicated to providing our customers with valuable information and deep insights through our Thought Leadership web platform. This platform features expert opinions, groundbreaking research, and strategic visions that shape the future of healthcare. Our articles cover various aspects of the industry including controlled release, regulatory, excipient insights, nitrosamine mitigation, operational excellence and more.

By sharing our knowledge and expertise, we aim to support our customers and industry in overcoming formulation challenges and driving innovation.

Conclusion

Digital health tools are transforming the pharmaceutical industry by enabling more efficient, data-driven solutions. By utilizing scalable technologies like advanced data analytics, artificial intelligence, and interoperable platforms, pharmaceutical companies can optimize operations and provide personalized patient experiences worldwide. By integrating these tools into our processes, we can enhance the development of excipients and formulations, ultimately benefiting patients and advancing healthcare.

Embracing digital health tools can accelerate drug development and transform pharmaceutical formulation processes. Whether you’re an experienced formulator or a startup, we’re here to support your journey. Let’s revolutionize pharmaceutical formulation together!

References:

¹The road to digital success in pharma | McKinsey
²Rewired pharma companies will win | McKinsey
³BASF Pharma Solutions and IFF Pharma Solutions… | BASF Pharma
⁴Capgemini and the digital health conversation: Insights from industry trailblazers - Capgemini